TLRY Tilray

Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

Tilray Brands, Inc. to Announce Third Quarter Fiscal 2025 Financial Results on April 8, 2025

NEW YORK and LEAMINGTON, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced that the Company will release financial results for its third quarter fiscal 2025 ended February 28, 2025 before financial markets open on April 8, 2025.

Live Conference Call and Audio Webcast

Tilray will hold a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed in the Investors section of Tilray's website at

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Media Contact:

Investor Contact:



EN
27/03/2025

Underlying

TLRYTilray

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE
Free
TLRY TILRAY

Unleashing the Spirit of Adventure: Breckenridge Distillery Launches M...

Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir Mountain Shot Delivers an Elevated Whiskey Experience, Blending Smooth Chocolate Notes with a Refreshing Hint of Mint BRECKENRIDGE, Colo., Aug. 21, 2025 (GLOBE NEWSWIRE) -- , an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to announce its latest innovation, , a crafted experience infused with the natural complexity of mushrooms and distilled into a moment of pure delight. Mountain Shot is a unique beve...

August 21, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Request...

Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today announced that the Company has submitted an application requesting an extension to regain compliance with Nasdaq’s listing standards regarding its price per share. The Company is evaluating several options including...

August 14, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Medical stringe una partnership strategica in Italia per render...

Tilray Medical stringe una partnership strategica in Italia per rendere più accessibili gli estratti di cannabis terapeutica FL Group, società di Tilray, collabora con Molteni, una grande azienda farmaceutica che si occupa di terapie del dolore e per il trattamento della dipendenza da sostanze NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, una divisione di Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) e leader mondiale nel settore della cannabis terapeutica, impegnata a rafforzare l'alleanza terapeutica tra pazienti e operatori sanitari per consentire decisioni s...

August 13, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access ...

Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts Tilray’s FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, announced today that its wholly-owned subsidiary, FL Group S.R.L., has...

August 13, 2025 1 EN
 PRESS RELEASE
Free
TLRY TILRAY

Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drin...

Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane’s and Happy Flower Brands NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- . (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions from its brands: and . Fizzy Jane’s, the sparkling seltzer line that debuted this spring in Georgia, North Carolina, and South Carolina, is now available in a 10mg HDD9 THC format, enhancing the buzz while keeping the same crisp, fruit-forward refreshment fans love. With 15...

August 12, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch